Hematech, a South Dakota-based biotech owned by Japan's Kyowa Hakko focused on developing antibodies in cattle, has laid off 18 workers. The layoffs--which include research positions--occurred after Kyowa slimmed down its antibody focus to cancer, immunology and kidney disease. Story